Items where Author is "Krickau, Tobias"

ELEFTHERIOU, Despina, CONNON, Roisin, TULLOH, Robert, MARTIN, Neil, KUCERA, Filip, CHRISTOV, Georgi, KAHN, Robin, MOSSBERG, Maria, NORDENHÄLL, Charlotta, BAILHACHE, Marion, PALMU, Sauli, WEBB, Carlotta, MCCROSSAN, Brian, HERBERG, Jethro, MORAES, Yolanda Collaco, MCCORMACK, Rachael, STONE, John, HUNTER, Rachael, WALKER, Ann Sarah, BROGAN, Paul, MERIDA MORILLAS, Marta, PURSELL, Molly, PAPADOPOULOU, Charalampia, ALOBAIDI, Muthana, MORAITIS, Elena, WALSH, Jo, MCLELLAN, Kirsty, ILINA, Maria, JANSEN, Marc, IRO, Mildred, DEWALS, Wendy, LAAN, Mari, VAN ONZENOORT, Lonneke, LANGER, Daniel, COLES, Will, PAULUS, Stephan, WILLIAMS, Eleri, NÚÑEZ-CUADROS, Esmeralda, ANTÓN, Jordi, HERTTING, Olof, DE SOMER, Lien, BERG, Stefan, PANZER, Joseph, MEERSCHAUT, Ilse, JÕGI, Piia, HUET, Frédéric, JEZIORSKI, Eric, VON BOTH, Ulrich, JAKOB, Andre, KRICKAU, Tobias, ROSINA, Silvia, SIMONINI, Gabrielle, TADDIO, Andrea, FERNANDEZ COOKE, Elisa, MILLER, Owen, SEFI, Elinor, LEVIN, Michael, SWALLOW, Veronica, WAN, Mandy, STANDING, Joseph, PANG, Kimberley and WYNCOLL, James (2026). Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD-CAA prevention (KD-CAAP) trial. eClinicalMedicine, 97: 104044. [Article]